Pharma companies home in on GLP-2s and GLP-3s in race to innovate on obesity treatments
Companies are looking at combining several hormone-like molecules to boost results.
How GLP-1s is shaping the future of healthcare, featuring expert insights, data-driven stories, and the latest industry developments.
Companies are looking at combining several hormone-like molecules to boost results.
A recent study from JAMA highlights what some worry are gaps in regulation.
We’re diving into new medicines and why they matter.
Galaxy Watch wearers will get alerts about health and exercise to see if they can maintain their strength.
A hot new GLP-1 bombshell has entered the villa.
The G in GLP-1 might as well stand for gold.
Pharma isn’t known for big-name celebrity appearances, but Ro’s approach could change the landscape.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.